{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:08:39Z","timestamp":1777100919232,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To estimate the value of FSCN1 in evaluating the prognosis and guiding the targeted therapy for patients with tongue squamous cell carcinoma (TSCC). Using the Oncomine database, we found some genes especially FSCN1 differentially expressed between TSCC samples and tongue normal samples. So we compared FSCN1 expression between TSCC and normal cell lines and knocked down FSCN1 in TSCC cells to observe its influence on the viability and trans-migration in vitro and tumor growth in vivo. Then we measured FSCN1 expression in human cancer tissues and adjacent non-carcinoma tissues (ANT) and explored the relationship between FSCN1 expression and clinical pathological factors and prognosis in TSCC patients. We found that FSCN1 is expressed higher in TSCC cells than in normal cells. Knockdown of FSCN1 reduced TSCC cell viability and trans-migration in vitro and impaired tumor growth in vivo. FSCN1 also expressed higher in human TSCC than in ANT. In addition, FSCN1 expression was related to N classification, clinical stage and relapse. TSCC patients with over-expression of FSCN1 had worse prognosis. In conclusion, over-expression of FSCN1 indicates worse prognosis for patients with TSCC and FSCN1 may be a potential prognostic biomarker and therapeutic target in TSCC.<\/jats:p>","DOI":"10.1038\/s41419-019-1574-5","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T11:02:26Z","timestamp":1556708546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma"],"prefix":"10.1038","volume":"10","author":[{"given":"Yue","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ye","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-kui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,1]]},"reference":[{"key":"1574_CR1","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1007\/s00405-016-4150-y","volume":"273","author":"M Seppala","year":"2016","unstructured":"Seppala, M. et al. High relative density of lymphatic vessels predicts poor survival in tongue squamous cell carcinoma. Eur. Arch. Otorhinolaryngol. 273, 4515\u20134524 (2016).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"1574_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oraloncology.2018.10.009","volume":"87","author":"BR Campbell","year":"2018","unstructured":"Campbell, B. R. et al. Early onset oral tongue cancer in the united states: a literature review. Oral Oncol. 87, 1\u20137 (2018).","journal-title":"Oral Oncol."},{"key":"1574_CR3","first-page":"869","volume":"1","author":"Y Zushi","year":"2011","unstructured":"Zushi, Y. et al. An in vitro multistep carcinogenesis model for both hpv-positive and -negative human oral squamous cell carcinomas. Am. J. Cancer. Res. 1, 869\u2013881 (2011).","journal-title":"Am. J. Cancer. Res."},{"key":"1574_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/bies.10070","volume":"24","author":"N Kureishy","year":"2002","unstructured":"Kureishy, N., Sapountzi, V., Prag, S., Anilkumar, N. & Adams, J. C. Fascins, and their roles in cell structure and function. Bioessays 24, 350\u2013361 (2002).","journal-title":"Bioessays"},{"key":"1574_CR5","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ceb.2004.07.009","volume":"16","author":"JC Adams","year":"2004","unstructured":"Adams, J. C. Roles of fascin in cell adhesion and motility. Curr. Opin. Cell Biol. 16, 590\u2013596 (2004).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1574_CR6","doi-asserted-by":"publisher","first-page":"74736","DOI":"10.18632\/oncotarget.20360","volume":"8","author":"PC Rodrigues","year":"2017","unstructured":"Rodrigues, P. C. et al. Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma. Oncotarget 8, 74736\u201374754 (2017).","journal-title":"Oncotarget"},{"key":"1574_CR7","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1158\/1078-0432.CCR-04-1378","volume":"11","author":"Y Hashimoto","year":"2005","unstructured":"Hashimoto, Y. et al. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin. Cancer. Res. 11, 2597\u20132605 (2005).","journal-title":"Clin. Cancer. Res."},{"key":"1574_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biopha.2015.05.014","volume":"73","author":"A Luo","year":"2015","unstructured":"Luo, A. et al. The clinical significance of fscn1 in non-small cell lung cancer. Biomed. Pharmacother. 73, 75\u201379 (2015).","journal-title":"Biomed. Pharmacother."},{"key":"1574_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16196-6","volume":"7","author":"CQ Wang","year":"2017","unstructured":"Wang, C.-Q. et al. Fscn1 gene polymorphisms: biomarkers for the development and progression of breast cancer. Sci. Rep. 7, 15887 (2017).","journal-title":"Sci. Rep."},{"key":"1574_CR10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/pin.12012","volume":"62","author":"SJ Kim","year":"2012","unstructured":"Kim, S. J. et al. Fascin expression is related to poor survival in gastric cancer. Pathol. Int. 62, 777\u2013784 (2012).","journal-title":"Pathol. Int."},{"key":"1574_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1309\/3PAM-P5WL-2LV0-R4EG","volume":"118","author":"A Maitra","year":"2002","unstructured":"Maitra, A. et al. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Am. J. Clin. Pathol 118, 52\u201359 (2002).","journal-title":"Am. J. Clin. Pathol"},{"key":"1574_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1023\/A:1026596609969","volume":"18","author":"W Hu","year":"2000","unstructured":"Hu, W. et al. Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis 18, 83\u201388 (2000).","journal-title":"Clin Exp Metastasis"},{"key":"1574_CR13","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1210\/jc.2018-01717","volume":"104","author":"G Poli","year":"2019","unstructured":"Poli, G. et al. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma. J. Clin. Endocrinol. Metab. 104, 1712\u20131724 (2019).","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"1574_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PAT.0000000000000124","volume":"46","author":"MH Koay","year":"2014","unstructured":"Koay, M. H., Crook, M. & Stewart, C. J. Fascin expression in cervical normal squamous epithelium, cervical intraepithelial neoplasia, and superficially invasive (stageia1) squamous carcinoma of the cervix. Pathology 46, 433\u2013438 (2014).","journal-title":"Pathology"},{"key":"1574_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4249-1","volume":"18","author":"Y Chen","year":"2018","unstructured":"Chen, Y., Tian, T., Mao, M. J., Deng, W. Y. & Li, H. Crbp-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma. BMC Cancer 18, 514 (2018).","journal-title":"BMC Cancer"},{"key":"1574_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14437","volume":"8","author":"HQ Ju","year":"2017","unstructured":"Ju, H. Q. et al. Mutant kras- and p16-regulated nox4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma. Nat. Commun. 8, 14437 (2017).","journal-title":"Nat. Commun."},{"key":"1574_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/jpi.12285","volume":"60","author":"HQ Ju","year":"2016","unstructured":"Ju, H. Q. et al. Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-kappab activation. J. Pineal Res. 60, 27\u201338 (2016).","journal-title":"J. Pineal Res."},{"key":"1574_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10555-007-9043-5","volume":"26","author":"S Yadav","year":"2007","unstructured":"Yadav, S., Zajac, E., Singhal, S. S. & Awasthi, S. Linking stress-signaling, glutathione metabolism, signaling pathways and xenobiotic transporters. Cancer Metastasis Rev. 26, 59\u201369 (2007).","journal-title":"Cancer Metastasis Rev"},{"key":"1574_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-32","volume":"12","author":"H Alam","year":"2012","unstructured":"Alam, H. et al. Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma. BMC Cancer 12, 32 (2012).","journal-title":"BMC Cancer"},{"key":"1574_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3892\/ijo.2013.2232","volume":"44","author":"SH Park","year":"2014","unstructured":"Park, S. H. et al. Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells. Int. J. Oncol. 44, 637\u2013646 (2014).","journal-title":"Int. J. Oncol."},{"key":"1574_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.canlet.2007.03.017","volume":"254","author":"TK Lee","year":"2007","unstructured":"Lee, T. K. et al. Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma. Cancer Lett. 254, 308\u2013315 (2007).","journal-title":"Cancer Lett."},{"key":"1574_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000081327","volume":"67","author":"Y Hashimoto","year":"2004","unstructured":"Hashimoto, Y., Shimada, Y., Kawamura, J., Yamasaki, S. & Imamura, M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 67, 262\u2013270 (2004).","journal-title":"Oncology"},{"key":"1574_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1267\/ahc.11032","volume":"44","author":"Y Shimamura","year":"2011","unstructured":"Shimamura, Y. et al. Immunohistochemical analysis of oral dysplasia: Diagnostic assessment by fascin and podoplanin expression. Acta. Histochem. Cytochem. 44, 239\u2013245 (2011).","journal-title":"Acta. Histochem. Cytochem."},{"key":"1574_CR24","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/nature08978","volume":"464","author":"L Chen","year":"2010","unstructured":"Chen, L., Yang, S., Jakoncic, J., Zhang, J. J. & Huang, X. Y. Migrastatin analogues target fascin to block tumour metastasis. Nature 464, 1062\u20131066 (2010).","journal-title":"Nature"},{"key":"1574_CR25","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3892\/mmr.2016.5421","volume":"14","author":"P Xiao","year":"2016","unstructured":"Xiao, P., Liu, W. & Zhou, H. Mir-200b inhibits migration and invasion in non-small cell lung cancer cells via targeting fscn1. Mol. Med. Rep. 14, 1835\u20131840 (2016).","journal-title":"Mol. Med. Rep."},{"key":"1574_CR26","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.3892\/ol.2016.5044","volume":"12","author":"X Yang","year":"2016","unstructured":"Yang, X., Lei, P., Huang, Y., Zhang, Z. & Zhang, Y. Microrna-133b inhibits the migration and invasion of non small cell lung cancer cells via targeting fscn1. Oncol. Lett. 12, 3619\u20133625 (2016).","journal-title":"Oncol. Lett."},{"key":"1574_CR27","doi-asserted-by":"publisher","first-page":"9707","DOI":"10.3892\/mmr.2017.7794","volume":"16","author":"S Yu","year":"2017","unstructured":"Yu, S. et al. Microrna663 suppresses the proliferation and invasion of colorectal cancer cells by directly targeting fscn1. Mol. Med. Rep. 16, 9707\u20139714 (2017).","journal-title":"Mol. Med. Rep."},{"key":"1574_CR28","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.3892\/or.2017.5549","volume":"37","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Mir-539 inhibits fscn1 expression and suppresses hepatocellular carcinoma migration and invasion. Oncol. Rep. 37, 2593\u20132602 (2017).","journal-title":"Oncol. Rep."},{"key":"1574_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ymthe.2018.09.018","volume":"27","author":"W Gao","year":"2019","unstructured":"Gao, W. et al. Promoter methylation-regulated mir-145-5p inhibits laryngeal squamous cell carcinoma progression by targeting fscn1. Mol. Ther. 27, 365\u2013379 (2019).","journal-title":"Mol. Ther."},{"key":"1574_CR30","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.molonc.2016.03.006","volume":"10","author":"S Han","year":"2016","unstructured":"Han, S. et al. Improving fascin inhibitors to block tumor cell migration and metastasis. Mol. Oncol. 10, 966\u2013980 (2016).","journal-title":"Mol. Oncol."},{"key":"1574_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8465","volume":"6","author":"FK Huang","year":"2015","unstructured":"Huang, F. K. et al. Targeted inhibition of fascin function blocks tumour invasion and metastatic colonization. Nat. Commun. 6, 7465 (2015).","journal-title":"Nat. Commun."},{"key":"1574_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027339","volume":"6","author":"M Al-Alwan","year":"2011","unstructured":"Al-Alwan, M. et al. Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules. PLoS ONE 6, e27339 (2011).","journal-title":"PLoS ONE"},{"key":"1574_CR33","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1002\/stem.2473","volume":"34","author":"R Barnawi","year":"2016","unstructured":"Barnawi, R. et al. Fascin is critical for the maintenance of breast cancer stem cell pool predominantly via the activation of the notch self-renewal pathway. Stem Cells 34, 2799\u20132813 (2016).","journal-title":"Stem Cells"},{"key":"1574_CR34","doi-asserted-by":"publisher","first-page":"27323","DOI":"10.1074\/jbc.M116.767640","volume":"291","author":"S Lin","year":"2016","unstructured":"Lin, S. et al. Monoubiquitination inhibits the actin bundling activity of fascin. J. Biol. Chem. 291, 27323\u201327333 (2016).","journal-title":"J. Biol. Chem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1574-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1574-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1574-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:00:43Z","timestamp":1671210043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1574-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1574-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]},"assertion":[{"value":"8 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"356"}}